702 related articles for article (PubMed ID: 25994816)
1. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
[TBL] [Abstract][Full Text] [Related]
2. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance.
Saxena R; Georgopoulos NA; Braaten TJ; Bjonnes AC; Koika V; Panidis D; Welt CK
Hum Reprod; 2015 Jun; 30(6):1454-9. PubMed ID: 25904635
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.
Li Q; Yan Z; Kuang Y; Zhou X; Jin L; He L; Sun X; Tao T; Wang L
Hum Reprod; 2016 Sep; 31(9):2150-7. PubMed ID: 27354380
[TBL] [Abstract][Full Text] [Related]
4. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
5. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
7. Chronic hyperandrogenemia in the presence and absence of a western-style diet impairs ovarian and uterine structure/function in young adult rhesus monkeys.
Bishop CV; Mishler EC; Takahashi DL; Reiter TE; Bond KR; True CA; Slayden OD; Stouffer RL
Hum Reprod; 2018 Jan; 33(1):128-139. PubMed ID: 29190387
[TBL] [Abstract][Full Text] [Related]
8. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
[TBL] [Abstract][Full Text] [Related]
9. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
[TBL] [Abstract][Full Text] [Related]
11. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
[TBL] [Abstract][Full Text] [Related]
12. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health.
Ruth KS; Beaumont RN; Tyrrell J; Jones SE; Tuke MA; Yaghootkar H; Wood AR; Freathy RM; Weedon MN; Frayling TM; Murray A
Hum Reprod; 2016 Feb; 31(2):473-81. PubMed ID: 26732621
[TBL] [Abstract][Full Text] [Related]
13. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
[TBL] [Abstract][Full Text] [Related]
14. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
15. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
17. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
18. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
